Health Care: Drugs

Opexa Therapeutics Inc (OPXA: NASDAQ)

$4.2 -0.02 | -0.47%
07/28/16 - 03:25 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 2.56M 1.27M 1.27M 0.00
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 2.56M 1.27M 1.27M 0.00
Selling, General, and Administrative Expenses 4.26M 3.83M 3.67M 2.51M
Research & Development 10.04M 12.12M 9.18M 6.32M
Operating Income before D & A (EBITDA) -11.74M -14.68M -11.59M -8.83M
Depreciation & Amortization 351.40K 387.78K 2.07M 466.35K
Interest Income 5.91K 15.46K 14.98K 280.00
Other Income - Net 67.53K 2.15K -2.48M 549.88K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -12.02M -15.05M -16.13M -8.74M
Interest Expense 0.00 1.98K 2.27M 350.30K
Pre-Tax Income -12.02M -15.05M -18.39M -9.09M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -12.02M -15.05M -16.66M -8.93M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -12.02M -15.05M -16.66M -8.93M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -12.02M -15.05M -16.66M -8.93M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-12.02M -15.05M -16.66M -8.93M
Preferred Dividends
Net Income Available To Common -12.02M -15.05M -16.66M -8.93M
Basic EPS from Continuing Ops. -2.05 -3.82 -8.85 -10.90
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.05 -3.82 -8.85 -10.90
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.05 -3.82 -8.85 -10.90
Basic Normalized Net Income/Share -2.05 -3.82 -8.85 -10.90
EPS fr Continuing Ops. -2.05 -3.82 -8.85 -10.90
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.05 -3.82 -8.85 -10.90
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.05 -3.82 -8.85 -10.90
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.05 -3.82 -8.85 -10.90
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with OPXA

Latest OPXA Headlines from TheStreet

More Financial News for OPXA

Press Releases for OPXA

See All Press Releases

Partner Headlines for OPXA

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter